LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - Protalix BioTherapeutics (NYSEAMEX: PLX)

Follow NYSEAMEX:PLX Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NYSEAMEX PLX Protalix BioTherapeutics
Melincoff Gwen A / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Forster Eliot / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Boudes Pol F / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Schwartz Aharon / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Elze Christian / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Ben Zvi Shmuel / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Bar-Shalev Amos / director
09/03/2025
Buy
$1.64
15,000
$25K
15,000
NYSEAMEX PLX Protalix BioTherapeutics
Naos Yaron / officer: Sr. VP, Operations
09/03/2025
Buy
$1.64
50,000
$82K
50,000
NYSEAMEX PLX Protalix BioTherapeutics
Bashan Dror / director, officer: PRESIDENT AND CEO
09/03/2025
Buy
$1.64
340,000
$558K
340,000

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous